Skip to content
Search

Latest Stories

GP CPCS delivers ‘unexpected’ insights across Greater Manchester

The GP Community Pharmacist Consultation Service (GP CPCS) is also delivering ‘unexpected’ insights to help transform patient care and facilitate integrated working between pharmacists and GPs across Greater Manchester.

Since April 2021, almost 14,000 appointments have been referred using the GP CPCS across the Greater Manchester Health and Social Care Partnership – a figure that is growing as its success gathers pace and they continue to support practices to increase referral activity.


Joshua Nolan, a pharmacist at Internet Pharmacy in Heywood, one of the first in the area to join the referral service, said: “The number of patients we’re seeing from GP CPCS has been building consistently month-on-month. On average we see around 50 patients, but recently we recorded 53 in just one week.”

The pharmacist, who has been practicing for six years and is also an independent prescriber, believes the GP CPCS has helped bring about more awareness to the clinical services community pharmacy can offer.

He said: “Community pharmacy is perfectly placed to help alleviate some of the pressure on GP practices. There’s more to us than dispensing medication and the support we provided during the pandemic, and through the GP CPCS, is helping raise awareness about the wide range of clinical services people can access through us.”

While the GP CPCS is achieving its objective of relieving the burden on general practice by directing patients with low acuity conditions for care within pharmacy, the Greater Manchester Health and Social Care Partnership has also gained an added benefit of being able to monitor the quality and uptake of the service thanks to the technology managing the referral process.

Alison Scowcroft, a member of the GP CPCS working group, said: “We’ve never had this insight before. The information we can access through EMIS software is helping us to paint a clear picture of where the GP CPCS is working well and where improvements need to be made. It’s helping to strengthen the collaboration between GP practices and community pharmacies.

“By examining the data, we can identify areas where we can improve, such as providing additional training to non-clinical staff to support them in better signposting patients who are suitable for the GP CPCS. The data is so important.”

The introduction of the GP CPCS across Greater Manchester has been well received by GPs. The majority of GP practices are now signed up to the GP CPCS with only 3 per cent still to join.

Luvjit Kandula, a member of the GP CPCS working group, said: “Our original aim was that by March this year, 50 per cent of GP practices would be live with the GP CPCS. But supported by the Winter Access Programme initiatives, we’ve far exceeded that, with 97 per cent of GP practices now signed up. We have seen great collaboration at a local level between general practice and community pharmacy.”

The working group adds that the data generated through EMIS software, during the referral process, is also helping them to better understand patient needs and how community pharmacy can further support the delivery of primary care.  Providing ‘unexpected, but vital’ healthcare insights.

Louise Gatley said: “Over the year we have seen the seasonal health trends you would expect – coughs, colds, and flu like symptoms during the winter months. But we’ve also seen some interesting trends that we can respond to.”

Through the data analytics the working group has been able to track a number of trends, identifying a high level of patients with minor skin conditions and 20 per cent of all referrals to date being for children under the age of 10-years-old.

Pharmacist, Joshua Nolan adds: “The majority of patients we see through the GP CPCS are children, with parents wanting advice and often just reassurance. Most of the referrals are about skin complaints, such as rashes, and more recently there has been an increase in people coming to us for help with Chickenpox and hand, foot and mouth disease.”

Diane Murphy, project officer, Greater Manchester Health and Social Care Partnership, said: “Getting the technology right to support GP CPCS was critical. From a commissioning perspective, the insight, as well as how simply the integration has been for pharmacists and GP practices, is important to ensure we get the full benefits of the service – helping clinicians and achieving better patient outcomes.”

More For You

Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair

Olivier Picard steps up as NPA chair, Basra as vice-chair

Olivier Picard named new NPA chair

The National Pharmacy Association (NPA) has announced Olivier Picard as the organisation’s new chair.

Picard replaces Nick Kaye whose term comes to an end this week.

Keep ReadingShow less
 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less
US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less